Clinical Trial Update: Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effect of dapagliflozin (Forxiga) on rhythm control outcomes in patients with atrial fibrillation; the study is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: Assiut University | Conditions: Dapagliflozin (Forxiga), Atrial Fibrillation (AF) | Phase 1 | Status: NOT_YET_RECRUITING